Status:
UNKNOWN
A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness
Lead Sponsor:
Medical Corps, Israel Defense Force
Conditions:
Simulator Sickness
Eligibility:
All Genders
21-50 years
Phase:
NA
Brief Summary
BACKGROUND:flight simulator have become an important component in pilot training. However, they are known to be associated with motion sickness like symptoms defined as Simulator Sickness (SS). Preven...
Eligibility Criteria
Inclusion
- age 21 to 50 years, qualified helicopter pilots
- history of average TS score in SSQ more than 7.48
Exclusion
- known vestibular, visual or central nervous system pathology
- fever of more than 37.2 degrees
- any MS like symptom prior to simulator training
- any compromising acute health problem
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01198106
Start Date
September 1 2009
End Date
September 1 2010
Last Update
September 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
base 30 IAF
Yavné, Israel